A Pilot Trial of Adjunctive Prednisone and Mycobacterium w Immunotherapy in Tuberculous Pericarditis.

Trial Profile

A Pilot Trial of Adjunctive Prednisone and Mycobacterium w Immunotherapy in Tuberculous Pericarditis.

Completed
Phase of Trial: Phase III

Latest Information Update: 26 Sep 2016

At a glance

  • Drugs Cadi 05 (Primary) ; Prednisolone; Prednisone
  • Indications Pericarditis; Tuberculosis
  • Focus Therapeutic Use
  • Acronyms IMPI
  • Most Recent Events

    • 02 Sep 2014 Status changed from active, no longer recruiting to completed, as per ClinicalTrials.gov record.
    • 08 Apr 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
    • 03 Jan 2012 Planned number of patients changed from 800 to 1400 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top